A major area of research activity by the database is the national surveillance of HIV-1 drug resistance, tracking changes in its prevalence over time. Analyses are done separately for drug-naïve patients to monitor transmitted drug resistance (TDR), and drug-experienced patients to monitor the extent of resistance by drug class and prevalence of multi-class resistance.